主要的终点事件是甲亢复发。
试验的主要终点事件是围手术期心肌梗死。
The primary end-point of this study would be periprocedural myocardial infarction.
主要终点事件：心血管死亡或非致死性心肌梗塞。
Main Outcome Measure: Cardiac death or nonfatal myocardial infarction (MI).
反之，正规应用药物治疗对终点事件的发生产生一定的保护作用。
Fifteen factors are associated with increased and 8 factors (mostly related to regular medication use) are associated with reduced occurrence of endpoints during follow up in this cohort.
微量白蛋白尿组发生联合终点事件的机率较正常UACR组高43%。
Patients with microalbuminuria were 43 percent more likely to reach the combined end point than those with normal UACR.
大量白蛋白尿组发生联合终点事件的机率较正常UACR组高75%。
Patients with macroalbuminuria were 75 percent more likely to reach the combined end point than those with regular UACR.
主要终点事件是射血分数、6分钟步行实验、明尼苏达生活质量分数的复合。
The primary end point was a composite of EF, distance on a 6-min walk test and Minnesota Living with Heart Failure Questionnaire (MLWHF) score.
主要终点事件包括心脏性死亡、Q波性心梗、再发心绞痛需要再次血运重建等。
The primary end point was defined as cardiac mortality, Q-wave myocardial infarction (MI), or refractory angina requiring revascularization.
因此，第一个实验证明在服用阿司匹林组的心血管终点事件显著减少，但总体获益有限。
Therefore the first trial demonstrated a significant reduction in cardiovascular end points with aspirin use, but limited overall benefit.
现有研究表明噻托溴铵能改善COPD的患者的多个终点事件，这就要求我们对噻托溴铵的长期疗效进行检验。
Previous studies showing that tiotropium improves multiple end points in patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term effects of tiotropium therapy.
在治疗结束时，蛋白酶体水平升高患者的中位生存期是30.2个月。蛋白酶体水平恢复正常的患者没有观察到终点事件。
Median survival at the end of treatment was 30.2 months in patients with elevated levels. This point was not reached in patients with normalized levels.
结果易化pci治疗与直接pci治疗比较，术中“罪犯”血管开通率、30天内主要终点事件发生率和出血事件发生率之间差异无显著性。
Results Compared with direct emergency PCI, criminal vascular patency rate, incidence of MACE within 30 day and bleeding events have not significantly different in facilitated emergency PCI group.
虽然这一事件很大程度上改变了这场两名选手争夺胜利的比赛，但他们都依然继续朝着终点线前进着。
Although this incident very much alters the race of the two participants competing for a win, both are going to continue on their way toward the finish line.
复合终点为初次致命或非致命性冠状动脉事件、卒中和血管重建。
Main Outcome Measures The primary end point was a composite of initial fatal or nonfatal coronary event or stroke or revascularization.
主要终点比较心血管不良事件，这些事件包括病人死亡的首要原因、非致死的心肌梗死、非致死的脑卒中。
Main outcome Measures Adverse cardiovascular outcomes, including the primary outcomes which was the first occurrence of all-cause death, nonfatal myocardial infarction, or nonfatal stroke.
主要终点是发生任何心血管事件。
The primary endpoint will be the onset of any cardiovascular event.
次要终点为心血管事件、肾功能和微血管病变。
Secondary end points were cardiovascular events, renal function, and microvascular morbidity.
初级终点为3个月时脱离透析。次级终点包括一年时肾脏和患者生存率以及严重的不良事件。
The primary end point was dialysis independence at 3 mo. Secondary end points included renal and patient survival at 1 yr and severe adverse event rates.
该事件在4月15号终点附近发生。
主要终点为主要不良心血管事件（MACE），定义为死亡，心肌梗塞（MI），休克和靶血管血运重建（TVR）。
The primary end point used was major adverse cardiac events (MACE), defined as death, myocardial infarction (MI), stroke and target vessel revascularization (TVR).
30天和一年的住院期间，其主要结局是缓慢流动/无复流现象（SF-NR）的发生，临床终点包括死亡、心肌梗死（MI）、靶病变血管血运重建术（TVR）和主要心脏不良事件（MACE）。
The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.
30天和一年的住院期间，其主要结局是缓慢流动/无复流现象（SF-NR）的发生，临床终点包括死亡、心肌梗死（MI）、靶病变血管血运重建术（TVR）和主要心脏不良事件（MACE）。
The primary outcome was the occurrence of SF-NR Clinical endpoints included death, MI, target vessel revascularization (TVR), and MACE during the hospitalization period, 30 days and at 1 year.
应用推荐